Press Releases

Press Releases

LEXINGTON, MA – July 23, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced it was named a final winner of GE and the NFL’s Head Health Challenge I’s phase two grant. There were…
LEXINGTON, MA – July 17, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it will be presenting at The Alzheimer’s Association International Conference (AAIC), July 18-23…
LEXINGTON, MA – June 15, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced an alliance with PBL Assay Science (PBL), naming the Company as a Preferred Partner for assay research…
LEXINGTON, MA – June 9, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced commercial availability of its multiplex panels, providing users with the ability to develop their own…
LEXINGTON, MA – June 1, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it is launching a series of conferences focused on the incredible potential and impact of…
LEXINGTON, MA – May 20, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that a study, prominently featuring Simoa’s multiplexing capabilities, has been published in The…
LEXINGTON, MA – March 31, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that RayBiotech, Inc., of Norcross, GA, has adopted its Simoa technology to deploy as part of their…
LEXINGTON, MA – March 16, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced it had appointed SCRUM, Inc., of Tokyo, Japan, as an exclusive distributor for sales and support of…
LEXINGTON, MA – March 5, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN), will use Quanterix…
LEXINGTON, MA – March 4, 2015 Quanterix Corporation, a leader in ultrasensitive single molecule measurement for the benefit of human health, today announced the appointment of Kevin Hrusovsky as Chief Executive Officer (“CEO”). Mr. Hrusovsky will continue to serve as Executive Chairman of its Board…